TNFRSF14 and bladder transitional cell carcinoma: Consequently, how the TNFRSF14–CD160 interaction might occur between NK cells and tumor cells in the BLCA tumor microenvironment to promote antitumor immunity and favorably impact patient prognosis remains unclear.